DRIEHAUS CAPITAL MANAGEMENT LLC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:54 am Sale | 2023-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | DRIEHAUS CAPITAL MANAGEMENT LLC | 5,039,477 7.540% | -585,267 (-10.41%) | Filing |
| 2023-02-08 11:32 am Purchase | 2022-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | DRIEHAUS CAPITAL MANAGEMENT LLC | 5,624,744 10.450% | 831,106 (+17.34%) | Filing |
| 2022-01-10 11:09 am Purchase | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | DRIEHAUS CAPITAL MANAGEMENT LLC | 4,793,638 10.090% | 4,793,638 (New Position) | Filing |